Corrigendum to "Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial" [Eur J Cancer 198 (2024) 113475].

Le Rhun, Emilie; Gorlia, Thierry; Felsberg, Jörg; Jongen, Joost; Maurage, Claude-Alain; Ducray, François; Gramatzki, Dorothee; Hau, Peter; Chinot, Olivier L; Preusser, Matthias; Cartalat, Stephanie; Roth, Patrick; van den Bent, Martin; Furtner, Julia; Collienne, Maike; Reifenberger, Guido; Weller, Michael

Le Rhun, Emilie; Gorlia, Thierry; Felsberg, Jörg; Jongen, Joost; Maurage, Claude-Alain; Ducray, François; Gramatzki, Dorothee; Hau, Peter; Chinot, Olivier L; Preusser, Matthias; Cartalat, Stephanie; Roth, Patrick; van den Bent, Martin; Furtner, Julia; Collienne, Maike; Reifenberger, Guido; Weller, Michael.

Afiliação

Le Rhun E; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland; Neuro-Oncology, General and Stereotaxic Neurosurgery
Gorlia T; European Organization for Research and Treatment of Cancer, Brussels, Belgium.
Felsberg J; Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Düsseldorf, Germany.
Jongen J; The Brain Tumour Center at the Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Maurage CA; Univ. Lille, UFR3S - Laboratoire d'Histologie, Lille, France.
Ducray F; CHU Lyon, Neuro-Oncology, Lyon, France.
Gramatzki D; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Hau P; Department of Neurology - NeuroOncology and Wilhelm Sander Neuro-Oncology Unit, University Hospital Regensburg, Regensburg, Germany.
Chinot OL; Neuro-oncology, CHU Timone, Marseille, France.
Preusser M; Division of Oncology, Department of Medicine 1, Medical University, Vienna, Austria.
Cartalat S; CHU Lyon, Neuro-Oncology, Lyon, France.
Roth P; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
van den Bent M; The Brain Tumour Center at the Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Furtner J; Department of Biomedical imaging and Image-guided Therapy, Medical University of Vienna, Austria; Research Center for Medical Image Analysis and Artificial Intelligence (MIAAI), Faculty of Medicine and Dentistry, Danube Private University, 3500 Krems, Austria.
Collienne M; European Organization for Research and Treatment of Cancer, Brussels, Belgium.
Reifenberger G; Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Düsseldorf, Germany.
Weller M; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.

Eur J Cancer ; 204: 114066, 2024 Jun.

Article em En | MEDLINE | ID: mdl-38658199

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur J Cancer Ano de publicação: 2024 Tipo de documento: Article